Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Infection in Developing Countries|April 3, 2020
Endolimax nana and urticariaStefano Veraldi, Luisa Angileri, Luisa Carlotta Rossi, et al.
Journal of Cosmetic Dermatology|May 2, 2021
Capryloyl glycine and soy isoflavonoids in hypertrichosis: An experimental and placebo-controlled clinical studyMauro Barbareschi, Federico Benetti, Elisa Gaio, et al.
Skin Appendage Disorders|February 4, 2022
Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic DermatitisMaurizio Romagnuolo, Mauro Barbareschi, Simona Tavecchio, et al.
Acta Dermato-Venereologica|September 14, 2021
Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic DermatitisSilvia Mariel Ferrucci, Simona Tavecchio, Luisa Angileri, et al.
Journal of Clinical Medicine|August 23, 2020
Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 PatientsSimona Tavecchio, Luisa Angileri, Francesco Pozzo Giuffrida, et al.
The Journal of Dermatology|October 6, 2015
Malignancies in bullous pemphigoid: A controversial associationRiccardo Balestri, Michela Magnano, Michelangelo La Placa, et al.
Journal of Clinical Medicine|April 13, 2024
Which Factors Are Associated with Persistence of Depressive and Anxiety Symptoms in Patients Affected by Atopic Dermatitis despite 2-Year Treatment with Dupilumab?Silvia Mariel Ferrucci, Simona Tavecchio, Alessandro Ceresa, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Assessment of Patient-Reported Outcomes at 48 Months of Treatment with Dupilumab for Severe Atopic Dermatitis: A Single-Center Real-Life Experience with 126 PatientsFrancesca Barei, Martina Zussino, Simona Tavecchio, et al.
Journal of Clinical Medicine|March 19, 2020
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life ExperienceSilvia Ferrucci, Giovanni Casazza, Luisa Angileri, et al.
The Journal of Dermatological Treatment|March 9, 2022
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface diseaseSilvia Ferrucci, Luisa Angileri, Simona Tavecchio, et al.
Pageof 2